Judge Snips DaVita Kickback Claims In FCA Suit

Law360, New York (May 11, 2011, 5:26 PM EDT) -- A Texas federal judge ruled Monday that a former Amgen Inc. employee failed to fully support claims in a qui tam False Claims Act suit accusing dialysis provider DaVita Inc. of receiving kickbacks in the form of educational grants from the drugmaker.

The relator, Ivey Woodard, claimed that DaVita violated the FCA by saying it was in compliance with the anti-kickback statute while it was accepting educational grants from Amgen in exchange for purchasing its blood drug Epogen, or EPO, a drug that stimulates red blood...
To view the full article, register now.




Case Information

Case Title

USA, ex rel., vs. Fresenius Medical

Case Number



Texas Eastern

Nature of Suit

Other Statutory Actions


Marcia A. Crone

Date Filed

March 21, 2005

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.